CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- EFFECT Other Notice of Effectiveness
- UPLOAD Other SEC-generated Letter
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- S-3 Offering Registration Statement
- 4 Open-market buy Director bought 19,644 shares at an average $1.36 ($26,769)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at an average $1.30 ($32,552)
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 54,167 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 27,084 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 8-K Event Material agreement
Page 23 of 30 · 581 filings